Psychedelic Bulletin #104 – Mydecine CEO Downplays Insider Activity; UC Davis Scores $2.7m to Study Non-hallucinogenic Psychedelics; Oregon Health Authority Adopts Rules

This Week: Mydecine CEO Downplays Concern Over Large Insider Activity and Late Filings UC Davis Scores $2.7m from NIDA to Explore Non-hallucinogenic Psychedelics Oregon Health Authority Adopts Products, Testing and Training Rules and more… Mydecine CEO Downplays Concern Over Large Insider Activity and Late Filings On Tuesday, Mydecine’s CEO, David Joshua Bartch (who generally goes by ‘Josh Bartch’…

Source